Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...
Ramona, a leader in advanced imaging solutions, is proud to announce the launch of the Vireotm, a groundbreaking live-cell imaging system designed to transform drug discovery. The Vireo leverages 24x ...
Ramona, a leader in advanced imaging solutions, is proud to announce the launch of the Vireo™, a groundbreaking live-cell imaging system designed to transform drug discovery. The Vireo leverages 24x ...
Signet Therapeutics ("Signet"), a clinical-stage biotech company leveraging organoids and AI to develop first-in-class cancer therapies, today announced that the first patient has been dosed in the ...